Gadolinium deposition in tissue following multiple contrast-enhanced MRI examinations
Othman Mohammed Mahzary University of Leeds || UK Introduction Since the initial approval to use gadolinium-based contrast agents (GBCAs) by the competent authorities, around 450 million doses of GBCAs have been administered around the world (1). Compared with many other pharmaceuticals (i.e. iodinated contrast agents), GBCA has been extremely favorable and considered safe due to […]
Gadolinium deposition in tissue following multiple contrast-enhanced MRI examinations Read More »